After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Prime Medicine Inc is $620.96M. A total of 2.49 million shares were traded on the day, compared to an average of 4.02M shares.
In the most recent transaction, GV 2021 GP, L.L.C. bought 1,500,000 shares of PRME for 3.30 per share on Aug 01 ’25. After the transaction, the 10% Owner now owns 3,262,440 company shares. In a previous transaction on Aug 01 ’25, NELSEN ROBERT bought 3,030,300 shares at 3.30 per share. PRME shares that Director owns now total 6,230,300.
Among the insiders who bought shares, ARCH Venture Partners XII, LLC acquired of 3,030,300 shares on Aug 01 ’25 at a per-share price of $3.30. This resulted in the 10% Owner holding 6,230,300 shares of PRME after the transaction. In another insider transaction, ARCH Venture Partners X, LLC bought 3,030,300 shares at $3.30 per share on Aug 01 ’25. Company shares held by the 10% Owner now total 6,230,300.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, PRME has a high of $6.94 and a low of $1.11.
As of this writing, PRME has an earnings estimate of -$0.24 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of -$0.19 per share and a lower estimate of -$0.31. The company reported an EPS of -$0.31 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PRME’s latest balance sheet shows that the firm has $269.62M in Cash & Short Term Investments as of fiscal 2021. There were $10.41M in debt and $57.98M in liabilities at the time. Its Book Value Per Share was $0.90, while its Total Shareholder’s Equity was $239.56M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PRME is Buy with a score of 4.23.
